Edmond de Rothschild Investment Partners

MedLumics announces Olivier Litzka, James Greene and Claudio Rumazza to its Board along with raising €34m Series B funding led by EdRIP

– SPAIN, Madrid – MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised 34.4 million Euros in financing that will be used to help advance the product and clinical development of the company’s AblaView catheter, intended for the treatment of atrial fibrillation (AF) and other arrhythmias.… => Read more

GamaMabs Pharma announces Gilles Nobecourt / Thierry Hercend to the Board after raising €15m series B financing round led by EdRIP

– FRANCE, Toulouse / Paris – Toulouse and Paris, France, December 15, 2015 – GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies for the treatment of cancer, today announces the completion of a €15m ($15.9m) series B financing round.… => Read more